JP2019526537A5 - - Google Patents

Download PDF

Info

Publication number
JP2019526537A5
JP2019526537A5 JP2019503703A JP2019503703A JP2019526537A5 JP 2019526537 A5 JP2019526537 A5 JP 2019526537A5 JP 2019503703 A JP2019503703 A JP 2019503703A JP 2019503703 A JP2019503703 A JP 2019503703A JP 2019526537 A5 JP2019526537 A5 JP 2019526537A5
Authority
JP
Japan
Prior art keywords
human insulin
zinc complex
acylated derivative
group
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019503703A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019526537A (ja
JP7432361B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2017/095377 external-priority patent/WO2018024186A1/zh
Publication of JP2019526537A publication Critical patent/JP2019526537A/ja
Publication of JP2019526537A5 publication Critical patent/JP2019526537A5/ja
Priority to JP2022066071A priority Critical patent/JP2022095872A/ja
Application granted granted Critical
Publication of JP7432361B2 publication Critical patent/JP7432361B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019503703A 2016-08-02 2017-08-01 ヒトインスリンまたはそのアナログのアシル化誘導体 Active JP7432361B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022066071A JP2022095872A (ja) 2016-08-02 2022-04-13 ヒトインスリンまたはそのアナログのアシル化誘導体

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CN201610625257 2016-08-02
CN201610625257.5 2016-08-02
CN201610779132.8 2016-08-31
CN201610779132 2016-08-31
PCT/CN2017/095377 WO2018024186A1 (zh) 2016-08-02 2017-08-01 一种人胰岛素或其类似物的酰化衍生物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022066071A Division JP2022095872A (ja) 2016-08-02 2022-04-13 ヒトインスリンまたはそのアナログのアシル化誘導体

Publications (3)

Publication Number Publication Date
JP2019526537A JP2019526537A (ja) 2019-09-19
JP2019526537A5 true JP2019526537A5 (enExample) 2020-07-02
JP7432361B2 JP7432361B2 (ja) 2024-02-16

Family

ID=61074099

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019503703A Active JP7432361B2 (ja) 2016-08-02 2017-08-01 ヒトインスリンまたはそのアナログのアシル化誘導体
JP2022066071A Pending JP2022095872A (ja) 2016-08-02 2022-04-13 ヒトインスリンまたはそのアナログのアシル化誘導体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022066071A Pending JP2022095872A (ja) 2016-08-02 2022-04-13 ヒトインスリンまたはそのアナログのアシル化誘導体

Country Status (6)

Country Link
US (1) US10815287B2 (enExample)
EP (1) EP3495384A4 (enExample)
JP (2) JP7432361B2 (enExample)
CN (2) CN108463468B (enExample)
TW (1) TWI747929B (enExample)
WO (1) WO2018024186A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111315766B (zh) * 2018-02-01 2023-05-12 江苏恒瑞医药股份有限公司 含人胰岛素类似物的酰化衍生物的药物组合物及其制备方法
US20210032307A1 (en) 2018-02-09 2021-02-04 Jiangsu Hengrui Medicine Co., Ltd. Codon optimized precursor gene and signal peptide gene of human insulin analogue
KR20210016400A (ko) 2018-05-24 2021-02-15 지앙수 헨그루이 메디슨 컴퍼니 리미티드 재조합 인간 인슐린 또는 그 유사체의 전구체를 제조하는 방법
TW202039539A (zh) 2018-12-11 2020-11-01 法商賽諾菲公司 具有經降低胰島素受體結合親和力的胰島素類似物
CN118206632A (zh) 2019-12-30 2024-06-18 甘李药业股份有限公司 胰岛素衍生物
WO2022111642A1 (zh) * 2020-11-27 2022-06-02 江苏恒瑞医药股份有限公司 一种制备胰岛素或其类似物的酰化衍生物的方法
CN112939771A (zh) * 2021-01-28 2021-06-11 宁夏蓝博思化学技术有限公司 长链烷基二酸单叔丁酯的制备方法
EP4347632A4 (en) 2021-05-24 2025-03-26 Sunshine Lake Pharma Co., Ltd. A novel acylated insulin analog
AU2022300061A1 (en) 2021-06-25 2024-02-01 Gan & Lee Pharmaceuticals Co., Ltd. Acylated insulin-containing pharmaceutical composition
US20250340610A1 (en) 2022-01-28 2025-11-06 Gan & Lee Pharmaceuticals Co., Ltd. Acylated insulin
CN117756914B (zh) * 2023-12-15 2024-09-03 瀚晖制药有限公司 依柯胰岛素的制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH25772A (en) 1985-08-30 1991-10-18 Novo Industri As Insulin analogues, process for their preparation
RU2164520C2 (ru) * 1993-09-17 2001-03-27 Ново Нордиск А/С Производное инсулина, растворимая пролонгированная фармацевтическая композиция, способ пролонгирования гипогликемического действия при лечении диабета
CN1163574A (zh) * 1994-11-17 1997-10-29 伊莱利利公司 酰化的胰岛素类似物
US6310038B1 (en) * 1997-03-20 2001-10-30 Novo Nordisk A/S Pulmonary insulin crystals
US8003605B2 (en) * 2002-03-13 2011-08-23 Novo Nordisk A/S Minimising body weight gain in insulin treatment
JP4463814B2 (ja) * 2003-08-05 2010-05-19 ノボ ノルディスク アクティーゼルスカブ 新規のインスリン誘導体
SI2107069T1 (sl) 2003-08-05 2013-04-30 Novo Nordisk A/S Novi inzulinski derivati
CN101389650B (zh) 2005-12-28 2012-10-10 诺沃-诺迪斯克有限公司 包含酰化胰岛素和锌的组合物以及制备所述组合物的方法
ES2526924T3 (es) 2007-08-15 2015-01-16 Novo Nordisk A/S Insulinas con una fracción acilo que comprende unidades repetitivas de aminoácidos que contienen alquilenglicol
US8691759B2 (en) * 2008-03-18 2014-04-08 Novo Nordisk A/S Protease stabilized, acylated insulin analogues
US8935928B2 (en) * 2011-10-10 2015-01-20 Lockheed Martin Corporation Integrated air-cycle refrigeration and power generation system
WO2013086927A1 (zh) 2011-12-15 2013-06-20 上海恒瑞医药有限公司 人胰岛素类似物及其酰化衍生物
CN106496322A (zh) * 2015-09-07 2017-03-15 江苏恒瑞医药股份有限公司 人胰岛素或其类似物的酰化衍生物的制备方法
KR20180105236A (ko) * 2016-02-05 2018-09-27 메모리얼 슬로안-케터링 캔서 센터 줄기 세포-유래 외배엽 계통 전구체의 분화 방법

Similar Documents

Publication Publication Date Title
JP2019526537A5 (enExample)
JP2022095872A5 (enExample)
JP2012512901A5 (enExample)
JP2011006428A5 (enExample)
RU99106518A (ru) Glp-1 производные
RU2008143668A (ru) Производное инсулина
JP2016523241A5 (enExample)
WO2019117274A1 (ja) ペプチドの製造方法、及び塩基の処理方法
WO2011080102A3 (en) Glp-1 analogues and derivatives
JP2013526501A5 (enExample)
JP2015110654A5 (enExample)
RU2009122582A (ru) Пэг-модифицированный эксендин или аналог эксендина и его композиции и применение
JP2007523881A5 (enExample)
EP3495384A1 (en) Acylated derivative of human insulin or analogue thereof
KR970042553A (ko) 캠프토테신 유도체
RU2008141280A (ru) Агонисты рецептора нейромедина u и их применение
CA3084688A1 (fr) Solution injectable a ph 7 comprenant au moins une insuline basale dont le pi est compris entre 5,8 et 8,5 et un co-polyaminoacide porteur de charges carboxylates et de radicaux hydrophobes
NZ599791A (en) Therapeutic peptides
RU2019109719A (ru) Конъюгаты полимиксин-альгинатных олигомеров
JP2009532384A5 (enExample)
RU2020108281A (ru) Новые ацилированные аналоги инсулина и варианты их применения
RU2019109728A (ru) Конъюгаты бацитрацин-альгинатный олигомер
EP3740227A1 (fr) Compositions sous forme d'une solution aqueuse injectable comprenant de l'amyline, un agoniste au recepteur de l'amyline ou un analogue d'amyline et un co-polyaminoacide
JP2014530882A5 (enExample)
JP2013516424A (ja) シクロスポリン類似体